Illumina Inks Supply Agreement with Natera for NIPT | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina said today that it has entered into a three-year supply agreement with Natera, under which Natera will run its noninvasive prenatal test Panorama on Illumina's HiSeq 2500 and use the associated Illumina consumables.

"This deal enables a major expansion of Natera's laboratory capacity to support the fast-growing demand for our Panorama test," Natera CEO Matthew Rabinowitz said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.